Search

Displaying results 5671 - 5680 of 10000 in total
  1. Drug

    Inlexisertib

    go.drugbank.com/drugs/DB21713
    Investigational

    Inlexisertib is a small molecule drug. The usage of the INN stem '-sertib' in the name indicates that Inlexisertib is a serine/threonine kinase inhibitor. … Inlexisertib has a monoisotopic molecular weight of 535.29 Da.

  2. Drug

    Lecufexor

    go.drugbank.com/drugs/DB21714
    Experimental

    Lecufexor is a small molecule drug. Lecufexor has a monoisotopic molecular weight of 618.05 Da.

  3. Drug

    Matsupexole

    go.drugbank.com/drugs/DB21715
    Experimental

    Matsupexole is a small molecule drug. Matsupexole has a monoisotopic molecular weight of 446.25 Da.

  4. Drug

    Balinatunfib

    go.drugbank.com/drugs/DB21728
    Investigational

    Balinatunfib is a small molecule drug. Balinatunfib has a monoisotopic molecular weight of 502.19 Da.

  5. Drug

    Cenacitinib

    go.drugbank.com/drugs/DB21735
    Investigational

    Cenacitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Cenacitinib is a Janus kinase inhibitor. … Cenacitinib has a monoisotopic molecular weight of 431.15 Da.

  6. Drug

    Certociclib

    go.drugbank.com/drugs/DB21736
    Investigational

    Certociclib is a small molecule drug. Certociclib is under investigation in clinical trial NCT05252416 ((VELA) Study of BLU-222 in Advanced Solid Tumors). … Certociclib has a monoisotopic molecular weight of 365.14 Da.

  7. Drug

    Rogocekib

    go.drugbank.com/drugs/DB21739
    Investigational

    Rogocekib is a small molecule drug. Rogocekib has a monoisotopic molecular weight of 408.15 Da.

  8. Drug

    Tersolisib

    go.drugbank.com/drugs/DB21752
    Investigational

    STX-478 is under investigation in clinical trail NCT05768139 (First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  9. Drug

    Afloqualone

    go.drugbank.com/drugs/DB21759
    Experimental

    Categories: Heterocyclic Compounds, 2-Ring
  10. Drug

    Daraxonrasib

    go.drugbank.com/drugs/DB22308
    ApprovedInvestigational

    RAS variants rather than a single mutation. … [L64039] It is a RAS(ON) tri-complex inhibitor that binds cyclophilin A and targets the active, GTP-bound ("ON") state of RAS, suppressing signaling of both wild-type and mutant RAS across the most common

    Categories: P-glycoprotein inhibitors, P-glycoprotein substrates